Table 1 Baseline characteristics of study subjects
| Â | 17-Hydroxyprogesterone Caproate | Placebo |
|---|---|---|
| Â | (N = 4) | (N = 8) |
Maternal Age (years) | 28 ± 3 | 33 ± 6 |
Gestational Age at PROM (weeks) | 25 ± 7 | 26 ± 4 |
Gestational Age at Randomization (weeks) | 28 ± 3 | 27 ± 3 |
   23.0-25.9 wks | 1 (25%) | 4 (50%) |
   26.0-28.9 wks | 1 (25%) | 1 (12.5%) |
   29.0-31.9 wks | 2 (50%) | 3 (37.5%) |
Interval from PROM to Randomization (days) | 3 (1-79) | 1.5 (0-29) |
Prepregnancy Weight (pounds) | 157 ± 35 | 162 ± 37 |
Body Mass Index (kg/M2) | 24 ± 7 | 27 ± 6 |
Body Mass Index > 30 kg/M2 | 1 (25%) | 3 (37.5%) |
Nulliparous | 3 (75%) | 5 (62.5%) |
History of Prior Preterm Birth | 0 | 0 |
Progestins Used Prior to 15 Weeks | 1 (25%) | 2 (25%) |
Conception | ||
   Spontaneous | 3 (75%) | 7 (87.5%) |
   In Vitro Fertilization | 1 (25%) | 0 |
   Intrauterine Insemination | 0 | 1 (12.5%) |
Married/Living with Partner | 3 (75%) | 7 (87.5%) |
College Education or More | 1 (25%) | 5 (62.5%) |
Ethnicity | ||
   Caucasian | 3 (75%) | 6 (75%) |
   African-American | 1 (25%) | 1 (12.5%) |
   Native American | 0 | 1 (12.5%) |
Reported Antepartum Substance Use | ||
   Alcohol, Rare | 0 | 1 (12.5%) |
   Marijuana | 1 (25%) | 1 (12.5%) |
   Tobacco | 0 | 2 (25%) |
   Other | 0 | 0 |